about
Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-AblHomeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemiaGene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individualsAnalyse multiple disease subtypes and build associated gene networks using genome-wide expression profiles.Response to imatinib mesylate in patients with hypereosinophilic syndrome.geneCBR: a translational tool for multiple-microarray analysis and integrative information retrieval for aiding diagnosis in cancer research.Immunophenotypic characterisation of acute leukaemia after polycythemia veraMolecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.Cytogenetic risk stratification in chronic myelomonocytic leukemia.A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples.MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblastsNovel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.Association between different risk factors and vascular accelerated ageing (EVA study): study protocol for a cross-sectional, descriptive observational studyAn international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrationsGene expression profiling in MDS and AML: potential and future avenues.Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia.Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance.Characterization by chromosome painting of balanced and unbalanced X chromosome translocations in myelodysplastic syndromes.Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method.Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.Uniparental disomy causes deficiencies of vitamin K-dependent proteins.Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma.Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.
P50
Q24302347-4F4A025E-597F-4753-8C72-49D2B1F82C89Q27312570-4DFA7B53-AD65-42A0-BC9B-2158B71A1227Q28255147-1CDB984F-BE6B-4B64-917E-DA696FE6BB80Q28285016-F57CF053-DAED-4324-BC52-B8346FD99A8AQ30488013-4A3B0A59-EA6F-44BB-B1BC-38832D661BB9Q33402403-83A092FE-0262-4D8D-AA40-ADCAE0F44FE0Q33470707-2F829624-EBF8-4AA0-88AA-4CDF750AE2FDQ33492521-43F41607-402E-4A1D-B708-C02AD5662173Q33671442-8DE5F601-8DCC-497D-BF2B-037FAAFA4CE3Q33707423-A7836E9A-1B1D-4D88-B20F-3E580B02BDB4Q33978937-1BF6AAB3-A652-4808-A527-3C7F8D5B0ED2Q34091328-31E7FA53-5628-4FF6-94B0-1E6B326BD838Q34477348-6B85D9F9-009A-4ACF-96DE-7ABB68635CACQ34612592-9B19A00C-D9BD-4E5B-AD0F-A76154F9F9D2Q35314318-876889DF-4E15-4A97-BAEA-9A12C3CFAE2DQ35496723-A6356690-CCFB-48C6-8584-FA5AC330C99CQ35625385-368029DD-8858-4F41-BBF0-00A0155473C3Q35842194-94B29BEB-2913-4DA1-B0B6-852A543F681CQ35859176-2D0F0B28-F7BE-4831-B24C-C38E1DF82142Q35922398-98C7D443-D4E8-40A2-9805-8F5597D8A0A1Q35924308-385CC3EA-52AA-4E18-A530-44334C1C0BF8Q35977542-6EAD54E6-87FB-4023-B6C7-69870BF661B4Q36163825-099DD01F-FA75-46AB-AAD6-BA1D85806BC1Q37007069-FDE8A032-D8C2-44D9-A822-E493A7AA34C2Q37125395-C564BC46-1F74-4740-A816-EA89020934CDQ37228334-FF343B1E-D1E3-4700-9BD9-977D18511C71Q37318226-41D18E3E-0BCE-446C-A6E5-D01590678C2CQ37697093-B149B960-0F8E-4811-913B-3EBB939D26D0Q37858877-6277E9A6-E8A8-4E1B-AE6A-7BD1529ACB41Q38093349-300D62E5-3E7F-46F7-B21B-38B6473068BEQ38107912-85CE04F7-5833-4E88-A220-1DDFA2BEE26BQ38331348-5589CB9E-45F9-4A2B-80B6-14292E32BD53Q38484493-CD13CC18-E1FA-4ADB-AC24-4916548D5FB6Q38508867-964E8135-31A9-420B-8278-AEE3788F2D20Q38742500-FB5F6BAF-C0DB-471A-B5E8-3F83E3F87DFAQ38975200-1827D250-1533-4D9F-9D9E-8597CD74B49AQ39311207-8373EF41-90FA-4DA1-ACC8-CBC65EBA94BFQ39343194-30A6C8CB-8809-4DD1-9DED-ABB56457153DQ39570922-162AEA67-A2C4-46D8-A651-B3C8489E282EQ39689454-A56083D8-6AE3-4513-A5A3-DA6DDD26FAF1
P50
description
researcher
@en
wetenschapper
@nl
name
J M Hernandez
@en
J M Hernandez
@nl
type
label
J M Hernandez
@en
J M Hernandez
@nl
prefLabel
J M Hernandez
@en
J M Hernandez
@nl
P106
P31
P496
0000-0002-9661-9371